JPL Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

JPL Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101	Buy	+5	New	+$101	﹤0.01%	1623

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JPL Wealth Management's AMPH Position: Q2 2026 in Review

JPL Wealth Management opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 5 shares worth $101. The stake represents ﹤0.01% of the portfolio and ranks #1623 among its holdings.

210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

JPL Wealth Management held 5 shares of Amphastar Pharmaceuticals worth $101 as of Q2 2026.
Amphastar Pharmaceuticals was a new JPL Wealth Management position in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1623 holding.
210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.